These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6111606)

  • 21. Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.
    Ramzan IM; Levy G
    J Pharmacol Exp Ther; 1986 Mar; 236(3):708-13. PubMed ID: 3485196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
    Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
    J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of theophylline and 3-methylxanthine in guinea pigs. I. Single dose administration.
    Madsen SM; Ribel U
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):1-7. PubMed ID: 7223434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative plasma pharmacokinetics of theophylline and ethylenediamine after the administration of aminophylline to man.
    Cotgreave IA; Caldwell J
    J Pharm Pharmacol; 1983 Jun; 35(6):378-82. PubMed ID: 6135777
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of a sustained-release theophylline preparation in healthy subjects.
    Goto M; Nakamoto Y; Sugiyama M; Yamashina H
    J Pharmacobiodyn; 1983 Apr; 6(4):225-31. PubMed ID: 6620110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of intravenous dihydroxypropyl theophylline (dyphylline) in an aminophylline-sensitive patient, and its pharmacokinetic comparison with theophylline.
    Lawyer CH; Bardana EJ; Rodgers R; Gerber N
    J Allergy Clin Immunol; 1980 May; 65(5):353-7. PubMed ID: 7372953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.
    Dadashzadeh S; Tajerzaden H
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):77-83. PubMed ID: 11554438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of intravenous theophylline.
    Chrzanowski FA; Niebergall PJ; Mayock RL; Taubin JM; Sugita ET
    Clin Pharmacol Ther; 1977 Aug; 22(2):188-95. PubMed ID: 884920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of clinically important interaction between erythromycin and theophylline.
    Hildebrandt R; Gundert-Remy U; Möller H; Weber E
    Eur J Clin Pharmacol; 1984; 26(4):485-9. PubMed ID: 6734707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of lansoprazole on pharmacokinetics and metabolism of theophylline.
    Kokufu T; Ihara N; Sugioka N; Koyama H; Ohta T; Mori S; Nakajima K
    Eur J Clin Pharmacol; 1995; 48(5):391-5. PubMed ID: 8641328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and bioavailability of theophylline in horses.
    Errecalde JO; Button C; Baggot JD; Mulders MS
    J Vet Pharmacol Ther; 1984 Dec; 7(4):255-63. PubMed ID: 6512916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theophylline metabolism during the first month of life and development.
    Bonati M; Latini R; Marra G; Assael BM; Parini R
    Pediatr Res; 1981 Apr; 15(4 Pt 1):304-8. PubMed ID: 7220153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline [proceedings].
    Caldwell J; Lancaster R; Monks TJ; Smith RL
    Br J Clin Pharmacol; 1977 Oct; 4(5):637P-638P. PubMed ID: 911622
    [No Abstract]   [Full Text] [Related]  

  • 34. Pirenzepin does not alter the pharmacokinetics of theophylline.
    Sertl K; Rameis H; Meryn S
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):15-7. PubMed ID: 3557724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.
    Knoppert DC; Spino M; Beck R; Thiessen JJ; MacLeod SM
    Clin Pharmacol Ther; 1988 Sep; 44(3):254-64. PubMed ID: 3046811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced biotransformation of theophylline in marihuana and tobacco smokers.
    Jusko WJ; Schentag JJ; Clark JH; Gardner M; Yurchak AM
    Clin Pharmacol Ther; 1978 Oct; 24(4):405-10. PubMed ID: 688731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of theophylline and 3-methylxanthine in guinea pigs. II. Multiple dose administration.
    Madsen SM; Ribel U
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):8-12. PubMed ID: 7223441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of probenecid on the pharmacokinetics of aminophylline.
    Chen TW; Patton TF
    Drug Intell Clin Pharm; 1983 Jun; 17(6):465-6. PubMed ID: 6861638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enflurane, halothane, and aminophylline--uptake and pharmacokinetics.
    Berger JM; Stirt JA; Sullivan SF
    Anesth Analg; 1983 Aug; 62(8):733-7. PubMed ID: 6869859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.